OClawVPS.com
Lemonaid Health
Edit

Lemonaid Health

https://www.lemonaidhealth.com/
Last activity: 13.06.2025
Active
Categories: DeliveryDoctorDrugHealthTechHomeMessangerOnlineService
Empowering people to live better, happier lives through simple & affordable healthcare.
Followers
1.06K
Website visits
507.1K /mo.
Mentions
54
Location: United States, California, San Francisco
Employees: 201-500
Total raised: $88M
Founded date: 2013

Investors 5

Funding Rounds 4

DateSeriesAmountInvestors
21.03.2021Series B$33M-
04.08.2020Series B$33M-
11.06.2018Series A$11M-
22.05.2017Series A$11M-

Mentions in press and media 54

DateTitleDescription
18.06.2025The Genetic Gamble: 23andMe's Resurrection and the Fluoride DebateIn the world of biotech, fortunes can shift like sand. Just look at 23andMe. Once a titan of genetic testing, it faced a steep decline, filing for Chapter 11 bankruptcy in March 2025. But now, a phoenix rises from the ashes. Anne Wojcicki, ...
13.06.2025Anne Wojcicki to buy back 23andMe and its data for $305 millionAnne Wojcicki’s nonprofit will acquire substantially all of 23andMe’s assets for $305 million, the company announced Friday. 23andMe filed for Chapter 11 bankruptcy protection in March. Last month, Regeneron announced it would purchase most...
23.05.2025Regeneron’s Bold Move: The Acquisition of 23andMe and Its Implications for Genetic DataIn a world where data is the new gold, Regeneron Pharmaceuticals has struck a deal that could reshape the landscape of genetic testing and data privacy. The acquisition of 23andMe, a company once celebrated for its consumer DNA testing kits...
23.05.2025Regeneron’s Acquisition of 23andMe: A New Era for Genetic DataThe world of biotechnology is a complex web, and the recent acquisition of 23andMe by Regeneron Pharmaceuticals adds another layer to this intricate tapestry. For years, 23andMe has been a household name, known for its consumer DNA testing ...
20.05.2025Regeneron’s Bold Move: Acquiring 23andMe Amidst BankruptcyIn a dramatic twist of fate, Regeneron Pharmaceuticals is set to acquire 23andMe for $256 million. This deal comes on the heels of 23andMe’s bankruptcy, a stark contrast to its once-thriving status as a pioneer in genetic testing. The acqui...
20.05.202523andMe Has Found a Buyer—Here’s What Might Happen to Your Genetic DataA biotech future built on data: Regeneron’s acquisition of 23andMe blurs the line between pharmaceutical innovation and genetic surveillance. Unsplash+ It’s been a turbulent stretch for 23andMe, the consumer DNA testing company once famous ...
19.05.2025Regeneron Pharmaceuticals to buy 23andMe and its data for $256 millionRegeneron Pharmaceuticals is acquiring “substantially all” of 23andMe’s assets for $256 million following a bankruptcy auction. The drugmaker is buying 23andMe’s Personal Genome Service, Total Health and Research Services business lines, bu...
19.05.202523andMe Is Selling Its Customers' Genetic Data to Drug Maker Regeneron: 'The Power of Genetics and Data' The database includes DNA samples from about 15 million people.Genetic testing startup 23andMe, which filed for bankruptcy earlier this year, announced on Monday that it has agreed to sell the genetic data of its 15 million users, along with its core business, to drug developer Regeneron Pharmaceutical...
19.05.202523andMe's journey from DNA testing pioneer to bankruptcy sale23andMe's journey from DNA testing pioneer to bankruptcy sale By ReutersMay 19, 202512:34 PM UTCUpdated ago Text Small Text Medium Text Large Text Share X Facebook Linkedin Email Link Attendees purchase DNA kits at the 23andMe booth at the ...
19.05.2025Regeneron to buy bankrupt DNA testing firm 23andMe for $256 millionRegeneron to buy bankrupt DNA testing firm 23andMe for $256 million By ReutersMay 19, 202512:00 PM UTCUpdated ago Text Small Text Medium Text Large Text Share X Facebook Linkedin Email Link The Regeneron Pharmaceuticals company logo is seen...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In